SCHEMBL483903

SCHEMBL483903

O=[N+]([O-])c1ccccc1-c1ccc(Br)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.71
TDP1 Q9NUW8 4/20 0.71
GABRA1 P14867 2/20 0.48
GABRG2 P18507 2/20 0.48
GABRB3 P28472 2/20 0.48
GABRA5 P31644 2/20 0.48
GABRA3 P34903 2/20 0.48
GABRA2 P47869 2/20 0.48
GABRP O00591 1/20 0.48
GABRD O14764 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRB2 P47870 1/20 0.48
GABRA4 P48169 1/20 0.48
GABRE P78334 1/20 0.48
GABRA6 Q16445 1/20 0.48
GABRG1 Q8N1C3 1/20 0.48
GABRG3 Q99928 1/20 0.48
GABRQ Q9UN88 1/20 0.48
EIF4E P06730 1/20 0.47
MAPT P10636 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4199839 0.98 ALDH1A1 (0.69) ALDH1A1TDP1GABRA1GABRG2GABRB3
SCHEMBL2958562 0.84 ALDH1A1 (0.92) ALDH1A1TDP1KMT2AMEN1MAPK1
SCHEMBL30196067 0.84 ALDH1A1 (1.00) ALDH1A1TDP1KMT2AMEN1MAPK1
Benzene SCHEMBL28038982 0.84 ALDH1A1 (1.00) ALDH1A1TDP1KMT2AMEN1MAPK1
SCHEMBL44392 0.84 ALDH1A1 (1.00) ALDH1A1TDP1KMT2AMEN1MAPK1
SCHEMBL15796866 0.83 ALDH1A1 (0.54) ALDH1A1TDP1GABRA1GABRG2GABRB3
SCHEMBL6747891 0.82 ALDH1A1 (0.74) ALDH1A1TDP1KMT2AMEN1MAPK1
SCHEMBL7821087 0.82 ALDH1A1 (0.74) ALDH1A1TDP1KMT2AMEN1MAPK1
SCHEMBL15801518 0.82 ALDH1A1 (0.53) ALDH1A1TDP1GABRA1GABRG2GABRB3
SCHEMBL11792031 0.82 ALDH1A1 (0.88) ALDH1A1TDP1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4701391-A2 HETEROLEPTIC IRIDIUM COMPLEX Universal Display Corporation (US) 2026-02-25 EP disclosed
US-12550604-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2026-02-10 US disclosed
EP-3643721-B1 HETEROLEPTIC IRIDIUM COMPLEX UNIVERSAL DISPLAY CORP (US) 2026-01-28 EP disclosed
EP-3915996-B1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2025-09-10 EP disclosed
US-20240376140-A1 Metal Complexes, Methods, and Uses Thereof ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2024-11-14 US disclosed
US-20240268216-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEX EMITTERS CONTAINING PHENYL-PYRAZOLE AND ITS ANALOGUES UNIV ARIZONA STATE (US) 2024-08-08 US disclosed
US-12043633-B2 Metal complexes, methods, and uses thereof ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2024-07-23 US disclosed
US-20240180020-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-05-30 US disclosed
US-11930698-B2 Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2024-03-12 US disclosed
US-11910701-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2024-02-20 US disclosed
WO-2007057138-A2 PROCESS FOR THE PRODUCTION OF BIPHENYLS SYNGENTA PARTICIPATIONS AG (CH) 2007-05-24 WO disclosed
WO-2006092429-A1 METHOD FOR PRODUCING SUBSTITUTED BIPHENYLS BASF AKTIENGESELLSCAHFT (DE) 2006-09-08 WO disclosed
US-6362380-B1 REACTING 2-NITROCHLOROBENZENE AND A BORONIC ACID ; PALLADIUM CATALYST BASF AKTIENGESELLSCHAFT (DE) 2002-03-26 US disclosed
EP-0888261-B1 PROCESS FOR PREPARING NITROBIPHENYLENE BASF AG (DE) 2001-11-28 EP disclosed
EP-0888261-A1 PROCESS FOR PREPARING NITROBIPHENYLENE BASF AKTIENGESELLSCHAFT (DE) 1999-01-07 EP disclosed
WO-1997033846-A1 PROCESS FOR PREPARING NITROBIPHENYLENE BASF AKTIENGESELLSCHAFT (DE) 1997-09-18 WO disclosed
EP-0463931-B1 Amorphous copolymers, translucent to visible light, for applications in non linear optics THOMSON CSF (FR) 1996-04-24 EP disclosed
US-5264512-A Amorphous copolymers, transparent in the visible range, for non-linear optical applications THOMSON-CSF (FR) 1993-11-23 US disclosed
EP-0463931-A1 Amorphous copolymers, translucent to visible light, for applications in non linear optics THOMSON-CSF (FR) 1992-01-02 EP disclosed
US-4006017-A Photoconductive composition, article and process XEROX CORPORATION (US) 1977-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11910701-B2 Organic electroluminescent materials and devices ICOSLG, PDCD1LG2, NECTIN4 ALDH1A1 721/4885TDP1 1884/4885GABRA1 1335/4885
US-12043633-B2 Metal complexes, methods, and uses thereof SOD1, SOD3, XRCC6 ALDH1A1 3304/4885TDP1 1058/4885GABRA1 4620/4885
US-20240180020-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ICOSLG, PDCD1LG2, NECTIN4 ALDH1A1 721/4885TDP1 1884/4885GABRA1 1335/4885
US-20240268216-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEX EMITTERS CONTAINING PHENYL-PYRAZOLE AND ITS ANALOGUES PDCD1, PDCD11, TYMP ALDH1A1 1517/4885TDP1 247/4885GABRA1 2931/4885
US-20240376140-A1 Metal Complexes, Methods, and Uses Thereof SOD1, SOD3, XRCC6 ALDH1A1 3304/4885TDP1 1058/4885GABRA1 4620/4885
US-11930698-B2 Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues PDCD1, PDCD11, TYMP ALDH1A1 1517/4885TDP1 247/4885GABRA1 2931/4885
US-12550604-B2 Organic electroluminescent materials and devices ROS1, DNMT3A, PRDM9 ALDH1A1 1179/4885TDP1 2074/4885GABRA1 2372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.